Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) PT Raised to $217 at RBC Capital
July 24, 2019 6:47 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $217.00 (from $186.00) while maintaining an Outperform rating.
Big TAVR Beat; TAVR Market Accelerated In 2Q19... MoreEdwards Lifesciences (EW) PT Raised to $250 at Cowen
July 24, 2019 6:42 AM EDTCowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $210.00) while maintaining a Outperform rating.
The analyst commented, "EW printed a significant 2Q TAVR beat that will reinvigorate investor sentiment ahead of a string of anticipated back-half... More
Edwards Lifesciences (EW) Tops Q2 EPS by 5c, Offers FY and Q3 Guidance
July 23, 2019 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.38, $0.05 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.20-$5.40, versus the consensus of $5.29.... More
